0
Startups & Venture·November 19, 2026·1 min read

China AI Biotech Firm Raises $200 Million in Oman-Backed Round

Share

MegaRobo’s nearly $200M raise with Oman’s sovereign fund backing shows Gulf capital is now comfortable underwriting AI‑plus‑robotics drug discovery in China. Biotech operators should assume global competition for lab automation talent and hardware will tighten over the next 12–24 months.